Search results
Results from the WOW.Com Content Network
Jane Osbourn, OBE, is a scientist and former chair of the UK BioIndustry Association. [1]A Natural Sciences graduate of Queens' College, Cambridge, Osbourn completed several post-graduate qualifications before moving into industry at Cambridge Antibody Technology, that became MedImmune and AstraZeneca.
AstraZeneca plc (/ ˌ æ s t r ə ˈ z ɛ n ə k ə /) (AZ) is a British-Swedish [2] [3] [4] multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, United Kingdom. [5]
The consolidation of AstraZeneca's global R&D footprint will have an impact on sites in the United States. About 1,200 positions will leave Wilmington, while there will be an increase of about 300 ...
He previously held the role of Executive Vice President, Innovative Medicines & Early Clinical Development (IMED) Biotech Unit of AstraZeneca from April 2010 to December 2018. Since Pangalos has been working at AstraZeneca, the company's compound success rate from pre-clinical studies to launch has increased from 4% to >19%. [13]
Masimirembwa was born in 1967 in Zimbabwe [5] and received his BSc (Hons) and DPhil degrees in biochemistry from the University of Zimbabwe in 1993. [6] Fascinated by the then-emerging field of pharmacogenetics, he conducted studies at the Karolinska Institute in Sweden in 1995, [5] where he earned his PhD in Medical Biochemistry and Biophysics.
A total of 1,600 jobs were to be relocated over three years, mainly to Cambridge, but the company planned to continue non-R&D work at the site. [8] In March 2014, Alderley Park was purchased by Manchester Science Parks – a partnership between Manchester's academic centres and local councils, and investment company Bruntwood .
Golden triangle universities generally do well on international rankings, which strongly reflect research performance. Some global rankings, such as those produced by Times Higher Education (THE) and QS, correct for the sizes of institutions in calculating their results but others, such as the Academic Ranking of World Universities (ARWU), make ...
Alexion Pharmaceuticals was founded in 1992 at Science Park in New Haven, Connecticut by Steven Squinto and Leonard Bell, a physician at Yale New Haven Hospital and assistant professor of medicine and pathology at Yale School of Medicine.